Skip to content

Preoperative Intermittent Fasting versus Carbohydrate Loading to Reduce Insulin Resistance: a Randomised Controlled Trial

Preoperative Intermittent Fasting versus Carbohydrate Loading to Reduce Insulin Resistance: a Randomised Controlled Trial - The PRINCESS trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53870
Enrollment
75
Registered
2023-01-09
Start date
2023-03-20
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

no specific disease (patients undergoing orthopaedic surgery)

Interventions

Patients in the TRF group will follow a daily TRF regimen consisting of an 8h ad libitum eating period and a 16h water fasting period during the last two weeks before surgery, followed by routine pr

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult patients, above 18 years old; - Undergoing elective orthopaedic surgery; - Intermediate, major or complex surgery according to the Surgical Outcome Risk Tool (SORT; http://www.sortsurgery.com/) severity of surgery classification; - Scheduled for surgery at least 17 days from the date of screening; - Motivated to follow a time restricted feeding regimen. - Willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: - History of diabetes mellitus; - History of feeding or eating disorders; - History of delayed gastric emptying or gastroesophageal reflux - Active malignancy - Patients classified as ASA IV by the attending anaesthetist; - BMI = 35; - Outpatient or day case surgery; - Palliative surgery; - Participation in another clinical trial that is inferfering with the procedures or outcomes of the PRINCESS trial; - Patients unable to fully comply to study needs (e.g. legally incapable patients or patients unable to communicate in Dutch).

Design outcomes

Primary

MeasureTime frame
The primary outcome will be insulin resistance according to the homeostasis model of insulin resistance (HOMA-IR) on postoperative day 1.

Secondary

MeasureTime frame
- Decrease of HOMA-IR on postoperative day 1 compared to baseline - HOMA-IR on the morning of surgery (day 0) - Beta-cell function and insulin resistance based on the updated HOMA model (HOMA2) on day 0 and postoperative day 1 - Mean duration of the feeding period in the last 14 days before surgery - Glucose, C-peptide and insulin on day 0 and postoperative day 1 - The EQ-5D-5L utility score at multiple timepoints (see study protocol) - Quality of Recovery-15 (QoR-15) score on day 0 and postoperative day 1 - Change in body weight in the last 2 weeks before surgery - Average daily caloric intake during the last 2 weeks before surgery

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)